Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.5 (
5'-nucleotidase
)
3,167
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous studies utilizing enzyme histochemistry, electron microscopy, and immunohistochemistry have failed to establish the cell of origin in
Kaposi's sarcoma
. The authors have rigorously tested the prevailing hypothesis that the lesion defined as
Kaposi's sarcoma
is derived from vascular endothelial cells. They use seven markers to characterize endothelial cells: three antigens (Factor VIII-related antigen, HLA-DR/Ia, macrophage/endothelial antigens), three enzymes (
5'-nucleotidase
, ATPase, alkaline phosphatase), and lectin binding (Ulex europaeus I). They applied the markers first to normal skin and lymph node, and then to biopsy specimens from 40 patients with
Kaposi's sarcoma
. Normal blood vessel endothelium was positive for all seven markers, but normal lymphatic endothelium was negative for all of the markers except
5'-nucleotidase
and Ulex europaeus lectin. The neoplastic cells in 40 cases of
Kaposi's sarcoma
closely resembled those of normal lymphatic endothelium but not those of blood vessel endothelium. This suggests that
Kaposi's sarcoma
may originate in lymphatic endothelium.
...
PMID:Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. 298 60